Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09063Ceritinib1Completed1